900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Cx. smear: repeat 9 months	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyanamide compound	A component that fails to comply with the current editorial guidance.
Cyanate lyase	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyanide and hydrocyanic acid	Ambiguous
Cyanide antidote	A component that fails to comply with the current editorial guidance.
Cyanide compound	Ambiguous
Cyanide poisoning	A component that fails to comply with the current editorial guidance.
Cyanides and hydrocyanic acid causing toxic effect	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyanides causing toxic effect NOS	Limited component (foundation metadata concept)
Cyanocobalamin + folic acid	A component that is no longer current, useful, appropriate or acceptable.
Cyanocobalamin 100mcg/mL injection	A component that fails to comply with the current editorial guidance.
Cyanocobalamin 100mcg/mL injection solution 1mL vial	A component that fails to comply with the current editorial guidance.
Cyanocobalamin 100mcg/mL injection solution 30mL vial	A component that fails to comply with the current editorial guidance.
Cyanocobalamin 1mg/1mL injection	Ambiguous
Cyanocobalamin 1mg/mL injection	Moved elsewhere
Cyanocobalamin 1mg/mL injection solution 1mL ampule	A component that fails to comply with the current editorial guidance.
Cyanocobalamin 25micrograms nasal spray	A component that is no longer current, useful, appropriate or acceptable.
Cyanocobalamin 500mcg nasal spray	A component that is no longer current, useful, appropriate or acceptable.
Cyanocobalamin 500mcg/0.1mL intranasal gel	Ambiguous
Cyanocobalamin[57Co] 370kBq/mL oral solution	A component that is no longer current, useful, appropriate or acceptable.
Cyanocobalamin[57Co] capsule+cyanocobalamin[58Co] capsule	A component that fails to comply with the current editorial guidance.
Cyanocobalamin[58Co] 370kBq/mL oral solution	A component that is no longer current, useful, appropriate or acceptable.
Cyanotic attacks: [perinatal NOS] or [newborn]	Ambiguous
Cyanotic congenital heart disease NOS	Limited component (foundation metadata concept)
Cyathostoma species	Ambiguous
Cyathostomum	Ambiguous
CyberKnife	Erroneous component (foundation metadata concept)
Cycle of change stage	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cycle of change stage	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclic III nerve palsy	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclic edema	Erroneous component (foundation metadata concept)
Cyclic neutropenia	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclic neutropenia in Gray Collie dogs	Moved elsewhere
Cyclic proteinuria	Ambiguous
Cyclic ulcer	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclical neutropenia	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclical vomiting NOS	Limited component (foundation metadata concept)
Cyclizine lactate 50mg/mL injection solution 1mL ampule	Ambiguous
Cycloanemization	A component that is no longer current, useful, appropriate or acceptable.
Cyclobarbitone	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclobarbitone overdose of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclobarbitone poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclobenzaprine hydrochloride	A component that fails to comply with the current editorial guidance.
Cycloguanil - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cycloguanil poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclopentolate hydrochloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclopentolate hydrochloride + phenylephrine hydrochloride	Erroneous component (foundation metadata concept)
Cyclopentolate hydrochloride 0.5% conventional release eye drops	A component that is no longer current, useful, appropriate or acceptable.
Cyclopentolate hydrochloride 0.5% single-use eye drops	A component that is no longer current, useful, appropriate or acceptable.
Cyclopentolate hydrochloride 0.5% solution	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclopentolate hydrochloride 1% conventional release eye drops	A component that is no longer current, useful, appropriate or acceptable.
Cyclopentolate hydrochloride 1% preservative-free eye drops	A component that fails to comply with the current editorial guidance.
Cyclopentolate hydrochloride 1% single-use eye drops	A component that is no longer current, useful, appropriate or acceptable.
Cyclopentolate hydrochloride 1% solution	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclopentolate hydrochloride 2% eye drops	A component that is no longer current, useful, appropriate or acceptable.
Cyclophosphamide 1000mg/vial injection	A component that fails to comply with the current editorial guidance.
Cyclophosphamide 100mg/vial injection	A component that fails to comply with the current editorial guidance.
Cyclophosphamide 100mg/vial powder for injection	A component that fails to comply with the current editorial guidance.
Cyclophosphamide 1g/vial injection	A component that is no longer current, useful, appropriate or acceptable.
Cyclophosphamide 1g/vial powder for injection	A component that is no longer current, useful, appropriate or acceptable.
Cyclophosphamide 200mg/vial injection	A component that is no longer current, useful, appropriate or acceptable.
Cyclophosphamide 200mg/vial powder for injection	A component that is no longer current, useful, appropriate or acceptable.
Cyclophosphamide 20mg/mL infusion solution 100mL vial	A component that fails to comply with the current editorial guidance.
Cyclophosphamide 20mg/mL infusion solution 200mL vial	A component that fails to comply with the current editorial guidance.
Cyclophosphamide 20mg/mL infusion solution 50mL vial	A component that fails to comply with the current editorial guidance.
Cyclophosphamide 2g/vial injection	A component that is no longer current, useful, appropriate or acceptable.
Cyclophosphamide 500mg/vial injection	A component that is no longer current, useful, appropriate or acceptable.
Cyclophosphamide 500mg/vial powder for injection	A component that is no longer current, useful, appropriate or acceptable.
Cyclophosphamide overdose of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclophosphamide poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclopic monster	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cycloplegic agent	A component that fails to comply with the current editorial guidance.
Cycloplegic paralysis of accommodation	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cycloplegic preparation	A component that fails to comply with the current editorial guidance.
Cyclopropane	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclopropane [no agents]	Erroneous component (foundation metadata concept)
Cyclopropane gas	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cycloserine poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclosporin - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclosporin 100mg/mL s/f oral solution	Ambiguous
Cyclosporin 250mg/5mL oily infusion concentrate	Ambiguous
Cyclosporin 50mg/1mL oily infusion concentrate	A component that is no longer current, useful, appropriate or acceptable.
Cyclosporin A poisoning	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclosporin index	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclosporin index	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclosporin overdose of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclosporin poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclosporine 100mg gel capsule	A component that fails to comply with the current editorial guidance.
Cyclosporine 100mg/5mL solution	A component that is no longer current, useful, appropriate or acceptable.
Cyclosporine 100mg/mL solution	A component that is no longer current, useful, appropriate or acceptable.
Cyclosporine 250mg/5mL	Ambiguous
Cyclosporine 250mg/amp	Ambiguous
Cyclosporine 25mg gel	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclosporine 50mg gel	Erroneous component (foundation metadata concept)
Cyclosporine ophthalmic emulsion 0.05%	A component that is no longer current, useful, appropriate or acceptable.
Cyclothymia	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclothymia	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cyclothymia	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cycrin Tablets	Moved elsewhere
Cyesiophobia	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cylindrical cell papilloma uncertain whether benign or malignant	A component that is no longer current, useful, appropriate or acceptable.

Start Previous Page 319 of 1411 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)